Tina Islam

Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles.

Lee Josephson, L. Josephson, Tina Islam, 2009, Cancer biomarkers : section A of Disease markers.

The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.

G. Wolf, Tina Islam, 2009, Cancer biomarkers : section A of Disease markers.

Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT.

M. Gee, M. Harisinghani, U. Mahmood, 2010, Clinical imaging.

Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10.

M. Gee, M. Harisinghani, A. Saokar, 2010, Clinical imaging.

Overview of nanoparticle use in cancer imaging.

Mukesh G Harisinghani, M. Harisinghani, Tina Islam, 2009, Cancer biomarkers : section A of Disease markers.

Detection of lymph nodes in pelvic malignancies with Computed Tomography and Magnetic Resonance Imaging.

M. Harisinghani, M. Saksena, A. Saokar, 2010, Clinical imaging.

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.

R. Weissleder, M. Harisinghani, A. Zietman, 2009, Clinical imaging.

Detection of lymph nodes in pelvic malignancies with Computed Tomography and Magnetic Resonance Imaging.

M. Harisinghani, M. Saksena, A. Saokar, 2010, Clinical imaging.